750 GM Cefuroxime Sodium Injection IP

Get a Price/Quote

MOQ : 50 Vials

750 GM Cefuroxime Sodium Injection IP Specification

Packaging Type
Glass vial with outer box

Salt Composition
Cefuroxime Sodium 750 gm

Origin of Medicine
India

Life Span
36 months from manufacturing date

Pacakaging (Quantity Per Box)
1 vial per box

Brand Name
YOUR BRAND

Dosage Form
Injection IP

Indication
Bacterial infections sensitive to cefuroxime

Drug Type
Prescription

Ingredients
Cefuroxime Sodium

Physical Form
Powder for Injection

Function
Antibacterial/Infection treatment

Recommended For
Adults and children as prescribed by physician

Dosage
As directed by the physician

Dosage Guidelines
For IM/IV use only, as prescribed

Suitable For
All age groups under medical supervision

Quantity
750 gm per vial

Storage Instructions
Store below 25C, protect from light

Regulatory Compliance
IP (Indian Pharmacopoeia) standards

Batch Details
To be checked on vial/box

Contraindications
Known hypersensitivity to cephalosporins

Safety Warning
For IV/IM use only, keep out of reach of children

Use Exclusivity
For hospital and institutional supply

Administration Route
Intravenous (IV) or Intramuscular (IM)

Appearance
White to off-white powder

Reconstitution Required
Yes, with sterile water for injection

Prescription/Non Prescription
Prescription only

Shelf Packaging
Sealed box with vial and leaflet

Marketed By
Brand customizable

750 GM Cefuroxime Sodium Injection IP Trade Information

Minimum Order Quantity
50 Vials

Payment Terms
Cash in Advance (CID)

Supply Ability
1000 Vials Per Month

Delivery Time
2-5 Days

Main Domestic Market
All India

About 750 GM Cefuroxime Sodium Injection IP

Experience unrivaled effectiveness with exclusive 750 GM Cefuroxime Sodium Injection IP-perfect for hospital and institutional use. Take advantage of splendiferous savings with our prescription-only antibacterial formulation, designed to treat a broad range of bacterial infections sensitive to cefuroxime. Each glass vial contains white to off-white powder, requiring reconstitution with sterile water for injection. Compliant with IP standards, this medication is suitable for adults and children under physician supervision. Shelf-stable for 36 months, the product arrives sealed and ready for your organization. For IV/IM use only.

Therapeutic Utility and Usage Details

The 750 GM Cefuroxime Sodium Injection IP stands out for exclusive hospital and institutional administration, intended strictly for intravenous or intramuscular use as prescribed. Its core feature is its potent, broad-spectrum antibacterial activity, making it ideal for managing a wide range of bacterial infections in controlled environments. Materialized as a powder, it requires reconstitution with sterile water before administration. Best suited for adults and children under medical guidance, it offers splendiferous clinical versatility as directed by your healthcare provider.

Export Market, Delivery, and Assurance

YOUR BRAND 750 GM Cefuroxime Sodium Injection IP is delivered worldwide with stock ready for prompt dispatch. Export markets primarily include Asia, Africa, and Eastern Europe, ensuring hospitals receive timely supply. Our sample policy is customer-oriented with estimates available upon request. Stock is shipped from India, with every batch certified as per IP (Indian Pharmacopoeia). Cepuroxime Sodium injections are securely packed and documented, supporting guaranteed quality and compliance for dependable institutional use.

FAQ's of 750 GM Cefuroxime Sodium Injection IP:

Q: How is 750 GM Cefuroxime Sodium Injection IP administered?

A: This injection is administered either intravenously (IV) or intramuscularly (IM), depending on the physician's instructions. Reconstitution with sterile water for injection is required prior to administration.

Q: What specific bacterial infections can this product treat?

A: 750 GM Cefuroxime Sodium Injection IP treats bacterial infections sensitive to cefuroxime, such as respiratory tract infections, urinary tract infections, and skin infections as determined by medical evaluation.

Q: When should I avoid using Cefuroxime Sodium Injection IP?

A: Avoid using this medication if you have known hypersensitivity to cephalosporins or any ingredient in the formulation. Always consult with your prescribing physician for safety guidance.

Q: Where can I find batch details and expiry information?

A: Batch details, expiry date, and regulatory information are clearly printed on the vial and the outer box packaging for complete transparency.

Q: What are the primary benefits of choosing YOUR BRAND Cefuroxime Sodium Injection IP?

A: The unrivaled quality, regulatory compliance (IP standards), exclusive institutional distribution, and splendiferous shelf stability (36 months) provide healthcare providers with exceptional reliability and clinical efficacy.